PPARA and nonpapillary renal cell carcinoma: In kidney cancer, inhibiting PPARA through an antagonist or siRNA could induce apoptosis and cell cycle arrest of kidney cancer cell lines, and it has been proven to be a diagnostic and prognostic marker for ccRCC (Abu Aboud et al., 2013).